GSK plc
GSK
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The compaā¦ read more
Healthcare
Drug ManufacturersāGeneral
46 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$54.23
Price+0.73%
$0.39
1Y
Price
Market Cap
$109.232b
Large
Price/Earnings 3y Avg5y Avg
14.6x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in GBP.+22.8%
EBITDA Margin+7.4%
Net Profit Margin+17.4%
Free Cash Flow Margin+22.8%
EBITDA Margin+7.4%
Net Profit Margin+17.4%
Free Cash Flow MarginRevenue
$31.951b
+3.8%
1y CAGR+3.6%
3y CAGR+7.4%
5y CAGREarnings
$5.591b
+121.7%
1y CAGR+2.3%
3y CAGR+62.0%
5y CAGREPS
$2.72
+122.6%
1y CAGR+24.8%
3y CAGR+15.8%
5y CAGRBook Value
$15.928b
$61.011b
Assets$45.016b
Liabilities$17.689b
DebtDebt to Assets
29.0%
1.5x
Debt to EBITDAFree Cash Flow
$5.824b
+74.6%
1y CAGR+8.1%
3y CAGR+12.9%
5y CAGRNo items found.
Press Releases
Statements and updates from the company